Literature DB >> 29380692

Cross-regulatory Circuit Between AHR and Microbiota.

Jian Ji1, Hao Qu1.   

Abstract

BACKGROUND: The gut microbes have a close symbiotic relationship with their host. Interactions between host and the microbiota affect the nutritional, immunological, and physiological status of the host. The Aryl Hydrocarbon Receptor (AHR) is a ligand activated transcription factor that mediates the toxicity of xenobiotics. Recently, the relationship between the gut microbiota and AHR has attracted the attention of many researchers.
METHODS: We undertook a structured search of bibliographic databases for peer-reviewed research literature.
RESULTS: We found and reviewed 49 peer-reviewed papers dealing with the major aspects related to the crosstalk between AHR and microbiota. The AHR influences the intestinal microbiota population and mediates host-microbe homeostasis. Interestingly, the gut microbiota also produces ligands of AHR from bacterial metabolism and thereby activates the AHR signaling pathway. Concusion: This review presents current knowledge of the cross-regulatory circuit between the AHR and intestinal microbiota. The findings of this review confirm the importance of AHR-microbiota interactions in health and disease. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Aryl hydrocarbon receptor (AHR); cross-regulatory; homeostasis; ligand; microbiota; xenobiotics.

Mesh:

Substances:

Year:  2019        PMID: 29380692     DOI: 10.2174/1389200219666180129151150

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  9 in total

1.  Presence or absence of microbiome modulates the response of mice organism to administered drug nabumetone.

Authors:  L Jourová; B Lišková; K Lněničková; N Zemanová; P Anzenbacher; P Hermanová; T Hudcovic; H Kozáková; E Anzenbacherová
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

Review 2.  Aryl hydrocarbon receptor: Its roles in physiology.

Authors:  Ziyue Kou; Wei Dai
Journal:  Biochem Pharmacol       Date:  2021-01-28       Impact factor: 5.858

Review 3.  Interkingdom Communication and Regulation of Mucosal Immunity by the Microbiome.

Authors:  Alexander D Ethridge; Malak H Bazzi; Nicholas W Lukacs; Gary B Huffnagle
Journal:  J Infect Dis       Date:  2021-06-16       Impact factor: 5.226

4.  Indigo Naturalis Alleviates Dextran Sulfate Sodium-Induced Colitis in Rats via Altering Gut Microbiota.

Authors:  Zhongmei Sun; Junxiang Li; Yi Dai; Wenting Wang; Rui Shi; Zhibin Wang; Panghua Ding; Qiongqiong Lu; Hui Jiang; Wenjing Pei; Xingjie Zhao; Yi Guo; Jiali Liu; Xiang Tan; Tangyou Mao
Journal:  Front Microbiol       Date:  2020-04-30       Impact factor: 5.640

Review 5.  The Microbiota/Host Immune System Interaction in the Nose to Protect from COVID-19.

Authors:  Arianna Di Stadio; Claudio Costantini; Giorgia Renga; Marilena Pariano; Giampietro Ricci; Luigina Romani
Journal:  Life (Basel)       Date:  2020-12-11

6.  The Ability of AhR Ligands to Attenuate Delayed Type Hypersensitivity Reaction Is Associated With Alterations in the Gut Microbiota.

Authors:  Osama A Abdulla; Wurood Neamah; Muthanna Sultan; Hasan K Alghetaa; Narendra Singh; Philip Brandon Busbee; Mitzi Nagarkatti; Prakash Nagarkatti
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 8.786

7.  The Impact of Environmental Chemicals on the Gut Microbiome.

Authors:  Karen Chiu; Genoa Warner; Romana A Nowak; Jodi A Flaws; Wenyan Mei
Journal:  Toxicol Sci       Date:  2020-08-01       Impact factor: 4.109

8.  Environmental Obesogens and Their Impact on Susceptibility to Obesity: New Mechanisms and Chemicals.

Authors:  Riann Jenay Egusquiza; Bruce Blumberg
Journal:  Endocrinology       Date:  2020-03-01       Impact factor: 4.736

9.  Tryptamine Attenuates Experimental Multiple Sclerosis Through Activation of Aryl Hydrocarbon Receptor.

Authors:  Nicholas Dopkins; William Becker; Kathryn Miranda; Mike Walla; Prakash Nagarkatti; Mitzi Nagarkatti
Journal:  Front Pharmacol       Date:  2021-01-25       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.